AI assistant
Sending…
SERKO LIMITED — Director's Dealing 2018
Jul 17, 2018
65804_rns_2018-07-17_da05974a-7bf1-4276-8df9-13273da32caa.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| ToNZX Limited; and | ||
|---|---|---|
| Name of listedissuer: | SerkoLimited (SKO) | |
| Date this disclosuremade: | 18-Jul-18 | |
| Date of last disclosure: | 14-Jul-17 | |
| Director or senior manager giving disclosure | ||
| Full name(s): | Robert (Bob) Shaw | |
| Name of listedissuer: | SerkoLimited (SKO) | |
| Name of related body corporate (ifapplicable): | SerkoTrusteeLimited | |
| Position heldin listedissuer: | ChiefStrategy Officer | |
| Summary of acquisition or disposal of relevant interest (excluding | ||
| specified derivatives) | ||
| Class of affected quoted financial products: | Ordinary Shares in Serko Limited (Ordinary Shares) | |
| Nature of the affected relevant interest(s): | Beneficial interest in Ordinary Shares with restrictive | |
| conditions allocated pursuant to the Serko Limited | ||
| Employee Restricted Share Scheme, held in trust | ||
| until vesting. These shares are subject to a deed | ||
| restricting exercise of voting rights attached to the | ||
| shares. | ||
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 34,209 Ordinary Shares with restrictive conditions | |
| (refer below for details of other relevant interests in | ||
| SerkoLimited Ordinary Sharesheld byMrShaw) | ||
| Number held in class after acquisition or disposal: | 59,130 Ordinary Shares with restrictive conditions | |
| (refer below for details of other relevant interests in | ||
| SerkoLimited Ordinary Sharesheld byMrShaw) | ||
| Current registered holder(s): | Serko Trustee Limited | |
| Registered holder(s) once transfers are registered: | Serko Trustee Limited | |
| Details of transactions giving rise to acquisition or disposal | ||
| Total number of transactions to which notice relates: | one | |
| Details of transactions requiring disclosure- | ||
| Date oftransaction: | 6-Jul-18 | |
| Nature of transaction: | Allocation of Ordinary Shares, with restrictive | |
| conditions, pursuant to the Serko Limited Employee | ||
| Restricted Share Scheme to Robert Shaw. These | ||
| shares are subject to a deed restricting exercise of | ||
| voting rights attached to the shares. | ||
| Name of any other party or parties to the transaction (if known): | Serko Trustee Limited is the registered holder of the | |
| shares until they vest. | ||
| The consideration, expressed in New Zealand dollars, paid or received for | Ordinary shares allocated as part of Mr Shaw's | |
| the acquisition or disposal. If the consideration was not in cash and cannot | remuneration package, at a value of $2.9594 per | |
| be readily by converted into a cash value, describe the consideration: | share (being the 20 day volume weighted average | |
| market price of Ordinary Shares on the NZX Main | ||
| Board through to 5 July 2018). | ||
| Numberof financialproducts towhichthe transaction related: | 24,921Ordinary Shareswith restrictive conditions | |
| If the issuer has a financial products trading policy that prohibits directors or | ||
| senior managers from trading during any period without written clearance (a | ||
| closed period) include the following details— | ||
| Whether relevant interests were acquired or disposed of during a closed | No | |
| period: | ||
| Whether prior written clearance was provided to allow the acquisition or | Not Applicable | |
| disposalto proceed during the closed period: | ||
| Date ofthe prior writtenclearance (ifany): | NotApplicable |
| Summary of other relevant interests after acquisition or disposal:Class of quoted financial products:Nature of relevant interest:_For that relevant interest,- _Number held in class:Current registered holder(s):For a derivative relevant interest,-Type ofderivative:Details of derivative,- | Summary of other relevant interests after acquisition or disposal:Class of quoted financial products:Nature of relevant interest:_For that relevant interest,- _Number held in class:Current registered holder(s):For a derivative relevant interest,-Type ofderivative:Details of derivative,- | |
|---|---|---|
| Ordinary Shares in Serko Limited | ||
| Registered holder and beneficial owner of12,884,296 ordinary shares | ||
| 12,884,296 ordinary shares | ||
| Robert Shaw and Geoffrey Robertson AshleyHosking as trustees oftheRipon Trust | ||
| NotApplicable | ||
| The notional value of the derivative (if any) or the notional amount ofunderlyingfinancialproducts (ifany): | Not Applicable | |
| A statement as to whether the derivative is cash settled or physically settled: | Not Applicable | |
| Maturity date ofthe derivative (ifany): | NotApplicable | |
| Expiry date ofthe derivative (ifany): | NotApplicable | |
| The price's specified terms (ifany): | NotApplicable | |
| Any other details needed to understand how the amount of theconsideration payable under the derivative or the value of the derivative isaffected by the value of the underlying financial products: | Not Applicable | |
| For that derivative relevant interest,- | ||
| Parties to the derivative: | Not Applicable | |
| If the director or senior manager is not a party to the derivative, the natureof the relevant interest in the derivative: | Not Applicable |
Certification
| Certification | ||
|---|---|---|
| I certify that, to the best of my knowledge and belief, the information | ||
| contained in this disclosure is correct and that I am duly authorised to make | ||
| this disclosure by all persons for whom it is made. | ||
| Signature of director or officer: | ||
| Date of signature: | 18-Jul-18 | |
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | ||
| Name and title of authorised person: |
More from SERKO LIMITED
Earnings Release
2026
May 19
Report Publication Announcement
2026
Apr 29
AGM Information
2026
Apr 15
Share Issue/Capital Change
2026
Mar 25
Regulatory Filings
2026
Mar 9
Director's Dealing
2026
Mar 4
Major Shareholding Notification
2026
Mar 2
Major Shareholding Notification
2026
Feb 26
Major Shareholding Notification
2025
Dec 21
Investor Presentation
2025
Dec 21